Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Aug 2, 2022 · 10-Q · 33 days after period end · 0000950170-22-013743
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$50.92M | -$36.55M | -$21.10M | -$87.76M |
| EPS Diluted | -$1.33 | -$1.00 | -$0.64 | -$13.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 2, 2022 · 33 d after period end
